Desuden bør patienter advares om risikoen for hypoglykæmi, når Efficib anvendes sammen med andre sulfonylurinstoffer.
In addition, patients should be alerted to the risk of hypoglycaemia when Efficib is used in combination with other sulfonylurea agents.